placeholder image
I. B. Hirsch All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Addressing the diabetes tsunami requires expanded access to diabetes technologies. 
    Journal of Diabetes Science and Technology. 2025
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 
    Diabetes Technology & Therapeutics. 2024
  • Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis. 
    Diabetes, Obesity & Metabolism. 2024
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. 
    Diabetes Technology & Therapeutics. 2023
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod庐 5 System. 
    Diabetes Research and Clinical Practice. 2022
  • Flash CGM is associated with reduced diabetes events and hospitalizations in insulin-treated type 2 diabetes. 
    Journal of the Endocrine Society. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
  • The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction. 
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Hypoglycemia in older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2016
  • Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 
    Diabetes care. 2016
  • Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research. 
    Diabetes care. 2015
  • Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes. 
    Diabetes care. 2015
  • Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 
    Diabetes care. 2015
  • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 
    Diabetes care. 2014
  • Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. 
    Diabetes care. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 
    Diabetes Technology & Therapeutics. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2013
  • Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents. 
    Diabetes care. 2008
    • Review
  • Use of continuous glucose monitoring when initiating glucagon-like peptide-1 receptor agonist therapy in insulin-treated diabetes [review]. 
    Diabetes, Obesity & Metabolism. 2024
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review]. 
    Diabetes Technology & Therapeutics. 2023
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
  • Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review]. 
    Diabetes Technology & Therapeutics. 2017
  • Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review]. 
    Diabetes Technology & Therapeutics. 2008
    • Abstract
  • Freestyle Libre system use is associated with reduction in inpatient and outpatient emergency acute diabetes events and all-cause hospitalizations in patients with type 2 diabetes [abstract]. 
    Diabetes. 2020
  • Utilization of continuous glucose monitors is associated with reduction in inpatient and outpatient emergency acute diabetes events regardless of prior blood test strip usage [abstract]. 
    Diabetes. 2020
  • Glucose variability in type 2 diabetes: the initial results of the FLAT-SUGAR trial [abstract 385-OR]. 
    Diabetes. 2015
  • Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P]. 
    Diabetes. 2015
    • Contact
    full name
  • I. B. Hirsch
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration